Coronary Artery Disease: Hypertension and Prognostic Score

Dr. Anthony Bavry, MD MPH Interventional Cardiology Assistant Professor of Medicine University of Florida 1600 SW Archer Road Gainesville, FL 32610MedicalResearch.com Interview with
Dr. Anthony Bavry, MD MPH
Interventional Cardiology
Assistant Professor of Medicine
University of Florida
1600 SW Archer Road
Gainesville, FL 32610

MedicalResearch.com: What are the main findings of the study?

Dr. Bavry: Among individuals with chronic stable coronary artery disease, it is possible to define a group who are at relatively low risk for adverse cardiovascular events.

MedicalResearch.com:Were any of the findings unexpected?

Dr. Bavry: The importance of low systolic blood pressure of imparting long-term risk to patients was unexpected. This finding could influence clinical decisions about how low blood pressure should be treated among these patients.

MedicalResearch.com: What should clinicians and patients take away from your report?

Dr. Bavry: Among patients with chronic stable coronary artery disease and systolic blood pressure < 110 mm Hg, consideration should be given to reducing anti-hypertensive therapy.

MedicalResearch.com: What recommendations do you have for future research as a result of this study?

Dr. Bavry:  Future research could use the INVEST risk score to assist in personalizing diagnostic/therapeutic decisions.

Citation:

Simple Integer Risk Score to Determine Prognosis of Patients With Hypertension and Chronic Stable Coronary Artery Disease

Anthony A. Bavry, Dharam J. Kumbhani, Yan Gong, Eileen M. Handberg, Rhonda M. Cooper‐DeHoff, and Carl J. Pepine

J Am Heart Assoc. 2013;2:e000205, originally published August 15, 2013, doi:10.1161/JAHA.113.000205